Citadel Advisors’s Rani Therapeutics RANI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $70.6K | Buy |
+137,349
| New | +$70.6K | ﹤0.01% | 5375 |
|
|
2025
Q1 | – | Sell |
-118,966
| Closed | -$163K | – | 6752 |
|
|
2024
Q4 | $163K | Buy |
118,966
+92,062
| +342% | +$126K | ﹤0.01% | 4966 |
|
|
2024
Q3 | $58.1K | Buy |
26,904
+12,139
| +82% | +$26.2K | ﹤0.01% | 5074 |
|
|
2024
Q2 | $56.1K | Buy |
14,765
+4,733
| +47% | +$18K | ﹤0.01% | 5146 |
|
|
2024
Q1 | $31.2K | Buy |
+10,032
| New | +$31.2K | ﹤0.01% | 5448 |
|
|
2023
Q3 | – | Sell |
-8,955
| Closed | -$36.9K | – | 6391 |
|
|
2023
Q2 | $36.9K | Sell |
8,955
-1,615
| -15% | -$6.65K | ﹤0.01% | 5085 |
|
|
2023
Q1 | $54.5K | Buy |
+10,570
| New | +$54.5K | ﹤0.01% | 5137 |
|